DAN PUCKETT - 22 Feb 2022 Form 4 Insider Report for Shockwave Medical, Inc.

Role
Chief Financial Officer
Signature
/s/ Wade Estey, as attorney-in-fact for Dan Puckett
Issuer symbol
N/A
Transactions as of
22 Feb 2022
Net transactions value
-$1,884,163
Form type
4
Filing time
24 Feb 2022, 18:19:48 UTC
Previous filing
15 Feb 2022
Next filing
20 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Options Exercise $1,024 +254 +0.49% $4.03* 51,661 22 Feb 2022 Direct
transaction SWAV Common Stock Options Exercise $60,639 +3,567 +6.9% $17.00* 55,228 22 Feb 2022 Direct
transaction SWAV Common Stock Sale $536,583 -3,821 -6.9% $140.43 51,407 22 Feb 2022 Direct
transaction SWAV Common Stock Tax liability $549,207 -3,907 -7.6% $140.57 47,500 22 Feb 2022 Direct
transaction SWAV Common Stock Sale $421,540 -2,800 -5.9% $150.55 44,700 22 Feb 2022 Direct
transaction SWAV Common Stock Sale $438,495 -2,762 -6.2% $158.76 41,938 23 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SWAV Stock Option Options Exercise $0 -254 -17% $0.000000 1,255 22 Feb 2022 Common Stock 254 $4.03 Direct F1
transaction SWAV Stock Option Options Exercise $0 -3,567 -20% $0.000000 14,430 22 Feb 2022 Common Stock 3,567 $17.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the stock options vest monthly beginning on 8/19/2018, subject to the continued service to the Issuer by the Reporting Person on each vesting date.
F2 1/48th of the stock options vest monthly beginning on 4/16/2019, subject to the continued service to the Issuer by the Reporting Person on each vesting date.